featured
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients With Solid Tumors Receiving Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients With Solid Tumors, Vaccinated Before or During Chemotherapy: A Randomized Trial
Cancer 2019 Feb 01;[EPub Ahead of Print], P Vink, I Delgado Mingorance, C Maximiano Alonso, B Rubio-Viqueira, KH Jung, JF Rodriguez Moreno, E Grande, D Marrupe Gonzalez, S Lowndes, J Puente, H Kristeleit, D Farrugia, SA McNeil, L Campora, E Di Paolo, M El Idrissi, O Godeaux, M López-Fauqued, B Salaun, TC Heineman, L OostvogelsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.